127 related articles for article (PubMed ID: 30537541)
1. A systematic review finds inconsistency in the measures used to estimate adherence and persistence to multiple cardiometabolic medications.
Alfian SD; Pradipta IS; Hak E; Denig P
J Clin Epidemiol; 2019 Apr; 108():44-53. PubMed ID: 30537541
[TBL] [Abstract][Full Text] [Related]
2. Communication and medication refill adherence: the Diabetes Study of Northern California.
Ratanawongsa N; Karter AJ; Parker MM; Lyles CR; Heisler M; Moffet HH; Adler N; Warton EM; Schillinger D
JAMA Intern Med; 2013 Feb; 173(3):210-8. PubMed ID: 23277199
[TBL] [Abstract][Full Text] [Related]
3. [Adherence to antihypertensive and lipid-lowering medications: a problem of public health, not yet resolved].
Grosso G; Raciti T; Marventano S; Romeo I; Mistretta A
Ann Ig; 2011; 23(2):173-84. PubMed ID: 21770233
[TBL] [Abstract][Full Text] [Related]
4. Different approaches to the assessment of adherence and persistence with cardiovascular-disease preventive medications.
Malo S; Aguilar-Palacio I; Feja C; Lallana MJ; Rabanaque MJ; Armesto J; Menditto E
Curr Med Res Opin; 2017 Jul; 33(7):1329-1336. PubMed ID: 28422521
[TBL] [Abstract][Full Text] [Related]
5. Systematic review of adherence rates by medication class in type 2 diabetes: a study protocol.
McGovern A; Tippu Z; Hinton W; Munro N; Whyte M; de Lusignan S
BMJ Open; 2016 Feb; 6(2):e010469. PubMed ID: 26928029
[TBL] [Abstract][Full Text] [Related]
6. Association between refill adherence to lipid-lowering medications and the risk of cardiovascular disease and mortality in Swedish patients with type 2 diabetes mellitus: a nationwide cohort study.
Karlsson SA; Hero C; Svensson AM; Franzén S; Miftaraj M; Gudbjörnsdottir S; Eeg-Olofsson K; Eliasson B; Andersson Sundell K
BMJ Open; 2018 Mar; 8(3):e020309. PubMed ID: 29602853
[TBL] [Abstract][Full Text] [Related]
7. Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy.
Benner JS; Chapman RH; Petrilla AA; Tang SS; Rosenberg N; Schwartz JS
Am J Health Syst Pharm; 2009 Aug; 66(16):1471-7. PubMed ID: 19667004
[TBL] [Abstract][Full Text] [Related]
8. Gender differences in cardiovascular disease risk management for Pacific Islanders in primary care.
Gu Y; Warren J; Walker N; Kennelly J
Qual Prim Care; 2013; 21(5):275-85. PubMed ID: 24119513
[TBL] [Abstract][Full Text] [Related]
9. Interventions to improve adherence to lipid lowering medication.
Schedlbauer A; Davies P; Fahey T
Cochrane Database Syst Rev; 2010 Mar; (3):CD004371. PubMed ID: 20238331
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes.
Iglay K; Cartier SE; Rosen VM; Zarotsky V; Rajpathak SN; Radican L; Tunceli K
Curr Med Res Opin; 2015; 31(7):1283-96. PubMed ID: 26023805
[TBL] [Abstract][Full Text] [Related]
11. Comparison of various measures for assessing medication refill adherence using prescription data.
Vink NM; Klungel OH; Stolk RP; Denig P
Pharmacoepidemiol Drug Saf; 2009 Feb; 18(2):159-65. PubMed ID: 19109809
[TBL] [Abstract][Full Text] [Related]
12. The Association Between Antihypertensive Medication Nonadherence and Visit-to-Visit Variability of Blood Pressure: Findings From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Kronish IM; Lynch AI; Oparil S; Whittle J; Davis BR; Simpson LM; Krousel-Wood M; Cushman WC; Chang TI; Muntner P
Hypertension; 2016 Jul; 68(1):39-45. PubMed ID: 27217410
[TBL] [Abstract][Full Text] [Related]
13. Medication adherence in randomized controlled trials evaluating cardiovascular or mortality outcomes in dialysis patients: A systematic review.
Murali KM; Mullan J; Chen JH; Roodenrys S; Lonergan M
BMC Nephrol; 2017 Jan; 18(1):42. PubMed ID: 28143438
[TBL] [Abstract][Full Text] [Related]
14. The modeled lifetime cost-effectiveness of published adherence-improving interventions for antihypertensive and lipid-lowering medications.
Chapman RH; Kowal SL; Cherry SB; Ferrufino CP; Roberts CS; Chen L
Value Health; 2010; 13(6):685-94. PubMed ID: 20825627
[TBL] [Abstract][Full Text] [Related]
15. Multimodal Interventions to Enhance Adherence to Secondary Preventive Medication after Stroke: A Systematic Review and Meta-Analyses.
Al AlShaikh S; Quinn T; Dunn W; Walters M; Dawson J
Cardiovasc Ther; 2016 Apr; 34(2):85-93. PubMed ID: 26820710
[TBL] [Abstract][Full Text] [Related]
16. Medication adherence and persistence according to different antihypertensive drug classes: A retrospective cohort study of 255,500 patients.
Schulz M; Krueger K; Schuessel K; Friedland K; Laufs U; Mueller WE; Ude M
Int J Cardiol; 2016 Oct; 220():668-76. PubMed ID: 27393848
[TBL] [Abstract][Full Text] [Related]
17. Importance of including early nonadherence in estimations of medication adherence.
Raebel MA; Carroll NM; Ellis JL; Schroeder EB; Bayliss EA
Ann Pharmacother; 2011 Sep; 45(9):1053-60. PubMed ID: 21852598
[TBL] [Abstract][Full Text] [Related]
18. Patients' Medication-Related Experience of Care Is Associated with Adherence to Cardiometabolic Disease Therapy in Real-World Clinical Practice.
Romanelli RJ; Huang Q; LaMori J; Doshi D; Chung S
Popul Health Manag; 2018 Oct; 21(5):409-414. PubMed ID: 29649391
[TBL] [Abstract][Full Text] [Related]
19. Self-reported barriers to medication use in older women: Findings from the Women's Health Initiative.
Marcum ZA; Vasan S; Tom S; Hart L; Wang Y; Shadyab AH; LaCroix AZ; Gray SL
J Am Pharm Assoc (2003); 2019; 59(6):842-847. PubMed ID: 31405806
[TBL] [Abstract][Full Text] [Related]
20. The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review.
Cramer JA; Benedict A; Muszbek N; Keskinaslan A; Khan ZM
Int J Clin Pract; 2008 Jan; 62(1):76-87. PubMed ID: 17983433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
